Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-5565 for post-herpetic neuralgia (Asian phase 3)
jRCT2080222691Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2014
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of mirogabalin in postherpetic neuralgia (PHN) (4 arms), sponsored by Daiichi Sankyo Co., Ltd. Started Dec 2014; status: completed.
02
Drugs
mirogabalin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on jRCT2080222691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222691.